The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Constitution Medical completes $20M offering

March 11, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Constitution Medical Investors Inc. of Westborough has completed a $20 million equity offering with 10 investors, including corporate officers and partners at Warburg Pincus LLC, according to a filing with the U.S. Securities and Exchange Commission.

Medical Imaging Taps New Levels of Graphics Display Technologies

March 11, 2011 9:34 am | by Nancy Pantone and Christine A. Van De Graaf | Articles | Comments

A major growth area in medical device technology, medical imaging is gaining momentum in the number of clinical applications for which it’s being prescribed. Now, new COM Express technology enables multi-display functionality for healthcare applications. This article reviews the new technology.


FDA eSubmitter (Radiation Safety Report Video Tutorial and Updated User Guide)

March 11, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration?s eSubmitter tool is part of an electronic submissions program that originated in the Center for Devices and Radiological Health (CDRH). The eSubmitter program is the result of two successful pilot programs at CDRH named..


Researchers link novel biomarkers to asthma and COPD

March 11, 2011 8:35 am | by EurekAlert | News | Comments

(American Thoracic Society) Four novel biomarkers have been identified which may aid in the diagnosis and management of asthma and chronic obstructive pulmonary disease, according to a study conducted by researchers in Australia, who determined the biomarkers may be used in different...


'Microparticles' useful in identifying earliest signs of emphysema

March 11, 2011 8:35 am | by EurekAlert | News | Comments

(American Thoracic Society) Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during...


Moody's Upgrades Mylan

March 11, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, March 11, 2011 /- Mylan Inc. (Nasdaq: MYL ) today reported that Moody's Investors Service ("Moody's") has upgraded the company's credit ratings, including the "Corporate Family Rating," to Ba2 from Ba3 (positive outlook). Following this action, Moody's rating outlook is...


Switch With Built-in Undervoltage Release Protects Operator Safety

March 11, 2011 7:02 am | Schurter, Inc. | Product Releases | Comments

The series, dubbed UP1, prevents uncontrolled restarts by monitoring and tripping under conditions of extreme voltage drop, or when the supply voltage is interrupted.

Modular Extruder Enables Rapid Changover

March 11, 2011 6:45 am | Product Releases | Comments

With a strong presence in the medical extrusion equipment market, American Kuhne has recently added to their impressive advanced technology extruder product line.


Charger for Lithium-Ion and Lithium Polymer Battery Pack

March 11, 2011 6:38 am | GlobTek, Inc. | Product Releases | Comments

GlobTek’s GS-2262 series of Li-ON chargers offers a compact and cost effective solution for charging GlobTek’s GL-523434A2 Lithium-Ion and Lithium Polymer battery pack.

Touch Screen Vision Sensors Deliver Ethernet Connectivity

March 11, 2011 6:34 am | Product Releases | Comments

Banner Engineering introduces the next generation of their popular iVu touch screen vision sensor family, the iVu Plus, adding Ethernet connectivity and more advanced inspection capabilities to the iVu’s intuitive platform.

Contrary to popular belief, not all cases of chronic pancreatitis are alcohol-induced

March 11, 2011 5:36 am | by EurekAlert | News | Comments

(American Gastroenterological Association) The relative rate of alcohol-related chronic pancreatitis is lower when compared to other causes.


Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. and LONDON, March 11, 2011 /- Tolerx, Inc. and GlaxoSmithKline (GSK) today announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12...


Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 11, 2011 /- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the...


Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 11, 2011 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments. "Our focus is working with Eisai to obtain FDA approval of lorcaserin, preparing to...


Qforma Appoints Two New Executives

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

SANTA FE, N.M., March 11, 2011 /- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of Elna Hamp to Vice President, Business Development and Joann Flynn to Marketing Manager. "As our clients' business models continue to evolve with the...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.